-
Use of RNA Sequencing for Discovery of Markers of Accommodation in Surveillance Biopsies from Recipients of an ABO-Incompatible Renal Transplant
-
Use of Tissue Plasminogen Activator (TPA) in Liver Transplantation from Donation After Cardiac Death (DCD) Donors: A Controlled Randomized Trial
-
Utility and Outcomes of Expanded Screening Among Live Solid Organ Donors
-
Utility of Anti-Phospholipase A2 Receptor (Anti-PLA2R) ELISA Testing in Predicting Post-Transplant Idiopathic Membranous Nephropathy (IMN)
-
Utilization and Characteristics of Kidney Donors in the US by OPTN-Defined Increased Risk Donor Status
-
Utilization and Characteristics of Liver Donors in the US by OPTN-Defined Increased Risk Donor Status
-
Utilization and Characteristics of Pancreas and Simultaneous Kidney-Pancreas Donors in the US by OPTN-Defined Increased Risk Donor Status
-
Utilization of Increased Risk Donors in a Canadian Multi-Organ Transplant Program
-
Utilization of Kidneys from Deceased Donors With Acute Kidney Injury
-
Utilization of Liver Allografts from Deceased Donors. Non Medical Causes for Discard. A Review of the SRTR Annual Report
2015 American Transplant Congress
May 2-6, 2015 in Philadelphia, Pennsylvania